[go: up one dir, main page]

PT98688A - Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol

Info

Publication number
PT98688A
PT98688A PT98688A PT9868891A PT98688A PT 98688 A PT98688 A PT 98688A PT 98688 A PT98688 A PT 98688A PT 9868891 A PT9868891 A PT 9868891A PT 98688 A PT98688 A PT 98688A
Authority
PT
Portugal
Prior art keywords
hydroxyethyl
chloro
methylthazole
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT98688A
Other languages
English (en)
Other versions
PT98688B (pt
Inventor
Curt-Eric Hagberg
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PT98688A publication Critical patent/PT98688A/pt
Publication of PT98688B publication Critical patent/PT98688B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98688A 1990-08-15 1991-08-14 Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol PT98688B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (sv) 1990-08-15 1990-08-15 New pharmaceutical formulations

Publications (2)

Publication Number Publication Date
PT98688A true PT98688A (pt) 1992-07-31
PT98688B PT98688B (pt) 1999-01-29

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98688A PT98688B (pt) 1990-08-15 1991-08-14 Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol

Country Status (26)

Country Link
US (1) US5385921A (pt)
EP (1) EP0619734B1 (pt)
JP (1) JP3094077B2 (pt)
AT (1) ATE164066T1 (pt)
AU (1) AU657490B2 (pt)
BG (1) BG97446A (pt)
CA (1) CA2088775A1 (pt)
CZ (1) CZ279586B6 (pt)
DE (1) DE69129126T2 (pt)
DK (1) DK0619734T3 (pt)
ES (1) ES2114891T3 (pt)
FI (1) FI930608A7 (pt)
HU (1) HUT65821A (pt)
IE (1) IE912818A1 (pt)
IL (1) IL99169A (pt)
IS (1) IS3743A7 (pt)
LT (1) LT3978B (pt)
LV (1) LV10921B (pt)
NO (1) NO303447B1 (pt)
NZ (1) NZ239329A (pt)
PT (1) PT98688B (pt)
RO (1) RO112994B1 (pt)
RU (1) RU2093155C1 (pt)
SE (1) SE9002659D0 (pt)
SK (1) SK8793A3 (pt)
WO (1) WO1992003134A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
CN103772313B (zh) * 2014-01-02 2015-10-14 郑桂富 一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) * 2020-10-26 2021-01-26 宜宾学院 油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (de) * 1978-06-14 1980-01-03 Basf Ag Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
JPH06500097A (ja) 1994-01-06
AU657490B2 (en) 1995-03-16
IS3743A7 (is) 1992-02-16
ATE164066T1 (de) 1998-04-15
CA2088775A1 (en) 1992-02-16
NO930452L (no) 1993-02-09
JP3094077B2 (ja) 2000-10-03
SE9002659D0 (sv) 1990-08-15
PT98688B (pt) 1999-01-29
IE912818A1 (en) 1992-02-26
IL99169A (en) 1995-10-31
HU9300388D0 (en) 1993-04-28
AU8409291A (en) 1992-03-17
ES2114891T3 (es) 1998-06-16
LV10921A (lv) 1995-12-20
CZ16693A3 (en) 1994-02-16
DK0619734T3 (da) 1998-10-05
FI930608A0 (fi) 1993-02-11
NO930452D0 (no) 1993-02-09
BG97446A (bg) 1994-03-24
IL99169A0 (en) 1992-07-15
RU2093155C1 (ru) 1997-10-20
US5385921A (en) 1995-01-31
FI930608L (fi) 1993-02-11
DE69129126D1 (de) 1998-04-23
SK8793A3 (en) 1993-07-07
LV10921B (en) 1996-08-20
LTIP1714A (en) 1995-09-25
CZ279586B6 (cs) 1995-05-17
DE69129126T2 (de) 1998-07-23
LT3978B (en) 1996-06-25
WO1992003134A1 (en) 1992-03-05
HUT65821A (en) 1994-07-28
EP0619734A1 (en) 1994-10-19
NZ239329A (en) 1994-11-25
RO112994B1 (ro) 1998-03-30
NO303447B1 (no) 1998-07-13
FI930608A7 (fi) 1993-02-11
EP0619734B1 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
FI20000084A7 (fi) Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi
PT100458A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo nomeadamente um antibiotico beta-lactamico
FI925342L (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
BR9100582A (pt) Derivados 3-arilpirrolidin-2,4-diona policiclicos,processo para sua preparacao,composicoes inseticidas,processo para combater insetos,aplicacao,processo para a preparacao de composicoes
FI940192A7 (fi) 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisi na aineina
MA23395A1 (fr) Procede de preparation de nouvelles formulations
FI913811L (fi) Menetelmä silmätipoiksi tarkoitetun koostumuksen valmistamiseksi
FI922806A0 (fi) Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
ES522107A0 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
FI911131L (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
FI924838A7 (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdannaisten valmistamiseksi
BR9100297A (pt) Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
FI911747L (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen aromaattisten sulfonamidijohdannaisten valmistamiseksi
PT98688A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol
FI913554L (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
BR9103479A (pt) Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto
FI915565L (fi) Menetelmä paikalliseen käyttöön tarkoitettujen farmaseuttisten koostumusten valmistamiseksi
RU93004984A (ru) Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
FI930967A0 (fi) Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner
DK573981A (da) Fremgangsmaade til fremstilling af cis-c-3",c4"-carbonatderivater af o-demethyl-oleandomycin og mellemprodukter herfor
BR9100399A (pt) Derivado de sulfonilureia substituido,composicao herbicida,processo para a preparacao de um derivado de sulfonilureia substituido
BR9100808A (pt) Derivado de 1,2,4-triazolil-propanol,processo para sua preparacao,composicoes fungicidas,aplicacao,derivados de propanol,processo para sua preparacao,oxiranas,processo para sua preparacao

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920310

FG3A Patent granted, date of granting

Effective date: 19981023

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020430